A new warning about _____ is on all labels of GLP-1 receptor agonists. True or False: Repetitive transcranial magnetic ...

The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

The warning affects all treatments containing GLP-1 receptor agonists, including semaglutide ( Ozempic, Wegovy, Rybelsus ), ...

A new study finds California's Proposition 65 law has reduced toxic chemical exposure nationwide, despite longstanding ...

The warning also was added to the Adverse Reactions section of the label, and to the Postmarketing ... Marilynn Larkin, MA, is an award-winning medical writer and editor whose work has appeared ...

PRESS CONFERENCE TODAY: Lawsuit Claims Birth Control Shot Linked To Brain Tumor Risk Eglet Law Group Sues Big Pharma ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

Smoking can cause a wide range of health issues. Affecting nearly every organ in the human body. According to the American ...

The FDA warns GLP-1 weight loss drug users of aspiration risks during anaesthesia Learn what this update means and how to stay safe before surgeries ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...